Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Kann Inspiration Mining die nächste 1.000 % Chance werden? Das Bohrprogramm startet in wenigen Tagen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PBJC | ISIN: US03837C1062 | Ticker-Symbol: BOV
Tradegate
12.05.26 | 21:13
3,480 Euro
+4,82 % +0,160
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
APYX MEDICAL CORPORATION Chart 1 Jahr
5-Tage-Chart
APYX MEDICAL CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
3,4603,50012.05.
3,4003,56012.05.

Aktuelle News zur APYX MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoApyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System182CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics products marketed and sold as Renuvion...
► Artikel lesen
APYX MEDICAL Aktie jetzt für 0€ handeln
FrApyx raises 2026 revenue outlook to $59M-$60M as AYON demand ramps2
DoApyx Medical Corp - 10-Q, Quarterly Report-
DoApyx Medical GAAP EPS of -$0.05 beats by $0.06, revenue of $12.5M beats by $1.73M1
DoApyx Medical Corp - 8-K, Current Report-
23.04.Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 20261
11.03.BTIG upgrades Apyx Medical stock rating on GLP-1 demand growth1
10.03.Apyx Medical Corp - 10-K, Annual Report1
10.03.Apyx Medical outlines 9%-11% revenue growth target for 2026 as AYON launch accelerates1
10.03.Apyx Medical GAAP EPS of -$0.03 beats by $0.03, revenue of $19.16M beats by $0.04M3
10.03.Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results390Reported record total revenue of $19.2 million in the fourth quarter of 2025Scaling U.S. commercial launch of AYON Body Contouring System (AYON) to meet strong market demandExpect FY2026 total revenue...
► Artikel lesen
10.03.Earnings Breakdown: Apyx Medical Q41
10.03.Apyx Medical Corp - 8-K, Current Report2
09.03.A Preview Of Apyx Medical's Earnings2
05.03.DeFi Development Corporation: DeFi Development Corp. to Host X Spaces Event with Apyx to Discuss Dividend-Backed Stablecoins4
12.01.Apyx Medical reports 34% revenue growth in Q4 20258
12.01.Apyx Medical reports preliminary Q4 revenue up about 34%3
12.01.Apyx Medical Corp - 8-K, Current Report-
16.12.25Roth/MKM initiates coverage on Apyx Medical stock with Buy rating1
16.12.25Roth/MKM startet Coverage für Apyx Medical mit Kaufempfehlung und 58 % Kurspotenzial2
Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1